🇰🇷 South Korea Country × Condition
breast cancer Clinical Trials in South Korea
Active clinical trials for breast cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 4, Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇰🇷 South Korea
Active Trials in South Korea (5)
NCT07198581
Recruiting
AI-Assisted Chemotherapy Side Effect Management
Enrollment
174 pts
Country
🇰🇷 South Korea
Incheon St.Mary's Hospital
View Trial → NCT06920810 Phase 4
Recruiting
Viscum Album for TNBC on Adjuvant Pembrolizumab
Enrollment
40 pts
Country
🇰🇷 South Korea
Ilsan Cha hospital
View Trial → NCT06686394 Phase 1, Phase 2
Recruiting
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Enrollment
81 pts
Country
🇰🇷 South Korea
Merck Sharp & Dohme LLC
View Trial → NCT06729684
Recruiting
Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
Enrollment
72 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Country
🇰🇷 South Korea
Jazz Pharmaceuticals
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in South Korea?
There are currently 5 active clinical trials for breast cancer with sites in South Korea, of which 5 are actively recruiting patients.
How can I join a breast cancer clinical trial in South Korea?
To join a breast cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in South Korea?
Active breast cancer trials in South Korea span Phase 4, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology